Key facts
- EMGenisys’s last known valuation is $6.0M (Sep 2024).
- It has raised $2.9M across 1 recorded rounds; the latest was Seed Round ($521K) in Sep 2024.
- Notable investors include Creative Destruction Lab, MedTech Innovator, Capital Factory, GrowthX Capital, Ag Ventures Alliance — 15 tracked in total.
- EMGenisys has filed 1 Form D with the SEC, most recently Oct 2024 ($521K sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for EMGenisys
Funding rounds
1 roundsAbout EMGenisys
Developer of a proprietary software platform designed to improve animal production and promote sustainability. The company's platform evaluates embryo morphokinetic activity in short observatory periods, scanning each embryo for signs of life, enabling livestock veterinarians and embryologists to improve the efficiency and success rates of breeding in cattle.
- Sector
- Information Technology
- HQ
- Driftwood, TX, United States
- Founded
- 2019
- Employees
- 6
- Website
- emgenisys.co/
- Ownership
- Privately Held (backing)
EMGenisys doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EMGenisys shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EMGenisys in its N-PORT filings yet. We sweep new filings monthly.